Ads
related to: Target
Search results
Health leaders plan staff cuts amid ‘substantial’ saving targets, survey finds
Press Association News via AOL· 3 hours agoThe majority of health leaders are considering cutting clinical and non-clinical staff to balance...
Nutanix shares maintain price target, Outperform rating with upbeat quarter By Investing.com
Investing.com· 8 hours agoOn Thursday, RBC (TSX:RY) Capital maintained its Outperform rating and $80.00 price target on shares...
Fed's Logan sees inflation trending toward 2% target By Investing.com
Investing.com· 5 hours agoLorie Logan, the President of the Dallas Federal Reserve Bank, said today that she sees inflation...
Jeep targets Tesla with $71,995 Wagoneer S, its 1st EV for US market
Detroit Free Press· 2 hours agoJeep is promising that its first fully electric model sold in the United States will deliver a...
Tsitsipas targets deep run but hopes to avoid 'fifth-set adventures'
Reuters· 18 minutes agoStefanos Tsitsipas is aiming to break his Grand Slam duck at the French Open but the former finalist...
Target Memorial Day sale 2024: 9 best deals to buy this week
Reviewed via Yahoo News· 3 days agoThe Target Memorial Day sale has some of the best deals and discounts on must-have brands like...
UiPath stock downgraded to neutral, price target slashed By Investing.com
Investing.com· 10 hours agoOn Thursday, BofA Securities adjusted its stance on UiPath Inc. (NYSE: NYSE:PATH), moving from a Buy...
Target’s Memorial Day sale is here — grab these 23 deals while they’re hot
CNN via Yahoo News· 3 days agoWhen you buy through links on our site, CNN and its syndication partners may earn a commission....
Stifel maintains $40 target on Celcuity, cites trial potential By Investing.com
Investing.com· 7 hours agoOn Thursday, Stifel, a brokerage firm, maintained its Buy rating and $40.00 price target for shares...
Oppenheimer maintains 'Outperform' on CATX with $2 target By Investing.com
Investing.com· 7 hours agoOn Thursday, Oppenheimer reiterated an Outperform rating on Perspective Therapeutics Inc (NYSE:CATX)...